BRYNJELSEN SEAN (CIK 1669976) reported 15 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-20). Recent activity: Sell ETON (8,978 shares), Sell ETON (47,307 shares), Sell ETON (36,373 shares), Sell ETON (7,342 shares), Buy ETON (27,500 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-20 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 8,978 | $562,472 |
| 2026-08-20 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 47,307 | $2.8M |
| 2026-08-20 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 36,373 | $2.2M |
| 2026-08-20 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 7,342 | $456,085 |
| 2026-07-14 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Buy | 27,500 | $0 |
| 2026-07-14 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Buy | 200,000 | $274,000 |
| 2026-05-29 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 119,852 | $3.8M |
| 2026-05-29 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 148 | $4,835 |
| 2026-01-14 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 5,015 | $77,181 |
| 2025-12-12 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 6,732 | $113,300 |
| 2025-06-05 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 60,945 | $1.1M |
| 2025-06-05 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 8,655 | $159,079 |
| 2025-06-05 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 400 | $7,608 |
| 2025-06-05 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 70,000 | $1.2M |
| 2025-06-05 | Eton Pharmaceuticals, Inc. (ETON) | President & CEO | Sell | 70,000 | $1.2M |
Source: SEC Form 4 filings · as of 2026-08-20